US 11344578
Immune cells expressing engineered antigen receptors
granted A61KA61K2039/55527A61K2239/31
Quick answer
US patent 11344578 (Immune cells expressing engineered antigen receptors) held by The Board of Regents of the University of Texas System expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/55527, A61K2239/31, A61K2239/38, A61K38/2086